Negative Segregation of a Rare KIF1A Variant in Familial Hyperekplexia Illustrates Pitfalls in Exome Interpretation

Technical Summary: Negative Segregation of a Rare KIF1A Variant in Familial Hyperekplexia

Problem Statement
The increasing utilization of whole-exome sequencing (WES) in neurologic disorders has improved diagnostic yields but simultaneously elevated the identification of rare variants of uncertain significance (VUS). A critical challenge in clinical neurogenetics is distinguishing truly pathogenic variants from incidental findings, particularly when genotype–phenotype correlations are incomplete or atypical. This paper addresses the specific scenario where a rare variant in a gene with broad neurologic associations (KIF1A) is identified in a family with a phenotype (familial exaggerated startle syndrome) that does not align with the established KIF1A-associated disorder spectrum (KAND). The study highlights the risk of misinterpreting biologically plausible but non-causative variants without rigorous segregation analysis.

Methodology
The study involved a three-generation family with an autosomal dominant pattern of inheritance characterized by exaggerated startle responses. The investigation proceeded through the following steps:

1. Clinical and Electrophysiologic Characterization: A 40-year-old proband and her affected daughter underwent comprehensive neurologic examinations, nerve conduction studies, needle electromyography (EMG), and surface EMG. The latter was used to confirm brainstem-mediated startle reflex activity.
2. Genetic Screening:
   • Targeted Sequencing: A next-generation sequencing (NGS) panel covering known hyperekplexia-associated genes (GLRA1, GLRB, SLC6A5, etc.) was performed first and returned negative results.
   • Whole-Exome Sequencing (WES): Conducted on the proband to identify rare candidate variants.
   • In Silico Analysis: Identified variants were evaluated for population frequency (gnomAD), evolutionary conservation, and deleteriousness predictions (SIFT, PolyPhen-2, MutationTaster).
3. Segregation Analysis: Sanger sequencing was performed on the affected daughter to verify the presence or absence of the candidate variant identified in the proband.
4. Classification: Variants were evaluated according to American College of Medical Genetics and Genomics (ACMG) guidelines.

Key Results

• Clinical Phenotype: The proband and her daughter presented with lifelong, non-progressive exaggerated startle responses triggered by auditory and tactile stimuli. Crucially, they lacked the hallmark features of KIF1A-associated disorders, including neonatal hypertonia, spasticity, pyramidal signs, peripheral neuropathy, developmental delay, cerebellar ataxia, or optic atrophy. Symptoms responded well to clonazepam.
• Genetic Findings: WES identified a heterozygous missense variant in KIF1A (NM_001244008.1:c.3242A>T; p.Lys1081Ile). This variant was absent from population databases, affected a highly conserved residue, and was predicted to be deleterious by multiple algorithms.
• Segregation Outcome: Despite the initial plausibility of the KIF1A variant, Sanger sequencing revealed that the affected daughter did not carry the variant.
• Variant Reclassification: Under ACMG guidelines, the variant met criteria for rarity (PM2) and computational support (PP3) but failed the segregation criterion (BS4) due to the lack of cosegregation in an affected first-degree relative. Consequently, the variant was reclassified as a VUS and deemed unlikely to be the causative etiology for this specific phenotype.

Significance and Claims
The paper asserts that this case illustrates the critical necessity of segregation analysis in the interpretation of exome data. The authors emphasize that:

• Biologic Plausibility is Insufficient: Even when a variant is rare, evolutionarily conserved, and predicted to be deleterious in a gene with neurologic relevance, the absence of cosegregation in affected family members provides definitive evidence against pathogenicity for that specific phenotype.
• Phenotype-Genotype Matching: Rigorous matching between the clinical presentation and the known disease spectrum is mandatory. The observed "isolated startle syndrome" diverges significantly from the broad KAND spectrum, further supporting the exclusion of the KIF1A variant.
• Limitations of Computational Tools: The study reinforces that in silico prediction tools alone cannot establish pathogenicity and that rare variants in highly expressed neuronal genes are frequently incidental findings.
• Unresolved Etiology: The authors modestly conclude that the molecular basis of the disease in this family remains unresolved. They suggest that the causative mutation may be a deep intronic or structural variant not captured by standard exome pipelines, or a variant in a novel or known hyperekplexia gene missed by current filters, potentially warranting whole-genome sequencing (WGS) in the future.

The paper does not propose new diagnostic algorithms or therapeutic interventions but serves as a cautionary report on the pitfalls of over-interpreting WES data without family-based validation.